MedTrace Logo

Cataract Surgery: Femto LDV Z8 Versus Conventional

NCT02351271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2019-10-23

Study results available
· View outcomes & findings →

Summary

The aim of the study is to demonstrate the performance and safety of the Femtosecond laser-assisted anterior capsulotomy and lens fragmentation on human eyes using the FEMTO LDV Z8 compared to conventional technique in cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

Femto LDV Z8

Femtosecond laser-assisted cataract pre-treatment: Capsulotomy and lens fragmentation, followed by ultrasound phacoemulsification

DEVICE

Manual capsulorhexis&lens fragmentation

Control treatment where the capsulorhexis is performed manually and the lens fragmentation is performed by the stop and chop technique with the phaco emulsification device

Sponsors & Collaborators

  • Ziemer Ophthalmic Systems AG

    lead INDUSTRY

Principal Investigators

  • Bojan Pajic, MD, PhD · Augenzentrum ORASIS AG

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-12-28
Completion
2017-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351271 on ClinicalTrials.gov